Form D · Other Technology

RxLive Inc.

St. Petersburg, FL · CIK 0001743807

Offering snapshot reported Sep 23, 2022 · SEC filing

Reported sold
$1.64M
Offering amount: $1.64M
Investors reported
8
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Apr 8, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 23, 2022Initial$1,640,000No comparison8SEC filing
Sep 23, 2022Initial$5,049,561No comparison6SEC filing
Apr 28, 2021Initial$1,996,539No comparisonNot reportedSEC filing
Oct 22, 2019Initial$850,000No comparison6SEC filing
Jun 21, 2018Initial$600,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-459679

Source: Form D, filed Sep 23, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Loraine Daugherty Director
Mark Engelen Director, Executive
Mar Engelen Director, Executive
Kristin Greco Director
Eliot Heller Director
Sean Mcnamara Director
Sean Mc Namara Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
1211 1 St Avenue N Suite 204
St. Petersburg, FL, 33705